USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ATERIS TECHNOLOGIES, LLC
Address:
910 Technology Blvd STE G
Bozeman, MT 59718-
Phone:
N/A
URL:
N/A
EIN:
156256873
DUNS:
606162084
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $862,139.00 3

Award List:

Development of a selective biosensor for detecting organophosphate pesticide expo

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$597,217.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant) This SBIR project is in response to the call for the development of field-deployable or wearable personal sensors for monitoring point-of-contact exposures to airborne chemicals through biosample testing. The broa d objective of this proposal is to develop… More

A NEW BIOSENSOR BASED ON CATASTROPHIC PROTEIN CHANGES

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$106,003.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase I project will test the idea that mechanostress-sensitive, fluorescent polymers can detect structural changes induced in proteins following reaction of the protein with small molecule inhibitors. This concept will be tested and proven using… More

Nanoparticle Defense for Agrichemical Exposures

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$158,919.00
Agency:
HHS
Principal Investigator:
Jon O. Nagy – 406-586-8420
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR project seeks to develop specialized protein-polymer nanoparticles that are engineered to a therapeutic drug to counter the ill effects following exposure to organophosphate (OP) insecticides. The concept for these nanoparticles is based on… More